Skip to main content
. 2023 Mar 7;23(4):121–130. doi: 10.1007/s11910-023-01259-1

Fig. 1.

Fig. 1

Summary of clinical (blue), genetic/environmental (orange), biochemical (green), and imaging (purple) markers that could be more relevant to define higher risk of PD conversion in GBA1-NMC and LRRK2-NMC. FC, functional connectivity; PBMCs, peripheral blood mononuclear cells; PRS, polygenic risk score